The International Experts Summit on Oncology & Cancer Care (Oncology Summit-2027) is a globally recognized platform that brings together oncologists, researchers, clinicians, and healthcare professionals to share insights and advancements in cancer care and research. The upcoming edition will be held from March 25–27, 2027, in Osaka, Japan, providing an opportunity for experts to collaborate, exchange knowledge, and discuss innovative approaches in oncology.
The summit will feature keynote sessions, scientific presentations, and panel discussions covering key areas such as cancer prevention, diagnosis, treatment, and patient care. It aims to promote collaboration and support the development of effective strategies to improve global cancer outcomes.
Join us in Osaka to connect with leading professionals, explore emerging research, and contribute to the advancement of oncology and cancer care.
Participants will also benefit from valuable networking opportunities, enabling meaningful collaborations across academia, healthcare, and industry. The summit encourages the exchange of ideas that can drive future innovations and improve patient outcomes worldwide
Abstract Submission Guidelines
International Experts Summit on Oncology & Cancer Care (Oncology Summit-2027)
March 25–27, 2027 | Osaka, Japan
The Scientific Committee invites researchers, clinicians, academicians, healthcare professionals, and industry experts to submit original abstracts related to oncology and cancer care. Accepted abstracts will be considered for Oral, Poster, or Virtual presentations.
Abstract Topics
Authors are encouraged to submit abstracts related to, but not limited to:
- Medical Oncology
- Clinical Oncology
- Radiation Oncology
- Surgical Oncology
- Cancer Biology
- Cancer Genetics & Genomics
- Precision Oncology
- Immunotherapy
- Targeted Therapy
- Cancer Prevention & Screening
- Cancer Epidemiology
- Breast Cancer
- Lung Cancer
- Gastrointestinal Cancers
- Hematologic Malignancies
- Pediatric Oncology
- Palliative Care
- Oncology Nursing
- Translational Cancer Research
- Cancer Survivorship
- Public Health Oncology
Abstract Format
Title
- The title should be concise and informative.
- Avoid abbreviations whenever possible.
Author Information
- Include full author names.
- Clearly identify the presenting author.
- Include institution, city, and country.
Abstract Structure
- Background
- Objectives
- Methods
- Results
- Conclusion
Word Limit
- Abstracts should contain 250–500 words.
- Title and author information are not included in the word count.
Language
- All abstracts must be submitted in English.
- Ensure proper grammar and scientific terminology.
Submission Requirements
- Abstracts must present original research, case studies, reviews, or clinical findings.
- Authors may submit multiple abstracts.
- All abstracts will undergo peer review by the Scientific Committee.
- The committee reserves the right to assign accepted abstracts to Oral, Poster, or Virtual presentation categories.
Presentation Types
- Oral Presentation
- Poster Presentation
- Virtual Presentation
Review Criteria
Abstracts will be evaluated based on:
- Scientific Quality
- Originality
- Relevance to Oncology and Cancer Care
- Methodological Rigor
- Clinical and Research Impact
Notification of Acceptance
Authors will receive notification of acceptance via email after the peer-review process.
Certificate & Publication
- All registered presenters will receive a Certificate of Presentation.
- Accepted abstracts may be included in the conference proceedings or abstract book.
Important Note
Submission of an abstract does not constitute registration. At least one author must complete conference registration for the abstract to be included in the final scientific program.
